M8891   Click here for help

GtoPdb Ligand ID: 12714

Synonyms: M-8891
Compound class: Synthetic organic
Comment: M8891 is an inhibitor of methionine aminopeptidase-2 (MetAP-2) [1]. It was developed for anti-tumour potential.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 5
Topological polar surface area 81.67
Molecular weight 385.36
XLogP 0.72
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC2=C(C=CN2)C=C1N3CC[C@](C(=O)NCC4=CC(=CC(=C4)F)F)(C3=O)O
Isomeric SMILES C1CN(C(=O)[C@]1(C(=O)NCC2=CC(=CC(=C2)F)F)O)C3=CC4=C(C=C3)NC=C4
InChI InChI=1S/C20H17F2N3O3/c21-14-7-12(8-15(22)10-14)11-24-18(26)20(28)4-6-25(19(20)27)16-1-2-17-13(9-16)3-5-23-17/h1-3,5,7-10,23,28H,4,6,11H2,(H,24,26)/t20-/m0/s1
InChI Key WVGGJQVCOTYFPV-FQEVSTJZSA-N
No information available.
Summary of Clinical Use Click here for help
M8891 was advanced to clinical evaluation as an oncology lead candidate, but development was discontinued at phase 1.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03138538 M8891 First in Human in Solid Tumors Phase 1 Interventional EMD Serono This clinical trial was terminated, and development of M8891 was discontinued (for business reasons).